Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

André Jefremow

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Best Practice & Research. Clinical Gastroenterology|December 7, 2021
New agents for immunosuppressionAndré Jefremow, Markus F Neurath
Visceral Medicine|March 11, 2021
SARS-CoV-2 Virus Manifestations in the Gastrointestinal Tract: Therapeutic ImplicationsAndré Jefremow, Markus F Neurath
Immunotargets and Therapy|December 4, 2020
All are Equal, Some are More Equal: Targeting IL 12 and 23 in IBD - A Clinical PerspectiveAndré Jefremow, Markus F Neurath
Visceral Medicine|May 2, 2020
Nanoparticles in GastrooncologyAndré Jefremow, Markus F Neurath
Cells|July 14, 2023
Novel Small Molecules in IBD: Current State and Future PerspectivesAndré Jefremow, Markus F Neurath
Frontiers in Cell and Developmental Biology|December 16, 2021
CRISPR/Cas9 in Gastrointestinal MalignanciesAndré Jefremow, Markus F Neurath, Maximilian J Waldner
Therapeutic Advances in Gastroenterology|November 17, 2025
JAK inhibitors in the management of extra-intestinal manifestations in inflammatory bowel diseaseFotios S Fousekis, André Jefremow, Konstantinos H Katsanos, et al.
The Journal of Experimental Medicine|November 25, 2010
VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancerMaximilian J Waldner, Stefan Wirtz, André Jefremow, et al.
Gastroenterology|September 21, 2023
p21 Prevents the Exhaustion of CD4<sup>+</sup> T Cells Within the Antitumor Immune Response Against Colorectal CancerOana-Maria Thoma, Elisabeth Naschberger, Markéta Kubánková, et al.
Journal of Crohn'S & Colitis|August 30, 2024
Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel DiseaseDominik Roth, Miriam M Düll, Ludwig J Horst, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Best Practice & Research. Clinical Gastroenterology|December 7, 2021
New agents for immunosuppressionAndré Jefremow, Markus F Neurath
Visceral Medicine|March 11, 2021
SARS-CoV-2 Virus Manifestations in the Gastrointestinal Tract: Therapeutic ImplicationsAndré Jefremow, Markus F Neurath
Immunotargets and Therapy|December 4, 2020
All are Equal, Some are More Equal: Targeting IL 12 and 23 in IBD - A Clinical PerspectiveAndré Jefremow, Markus F Neurath
Visceral Medicine|May 2, 2020
Nanoparticles in GastrooncologyAndré Jefremow, Markus F Neurath
Cells|July 14, 2023
Novel Small Molecules in IBD: Current State and Future PerspectivesAndré Jefremow, Markus F Neurath
Frontiers in Cell and Developmental Biology|December 16, 2021
CRISPR/Cas9 in Gastrointestinal MalignanciesAndré Jefremow, Markus F Neurath, Maximilian J Waldner
Therapeutic Advances in Gastroenterology|November 17, 2025
JAK inhibitors in the management of extra-intestinal manifestations in inflammatory bowel diseaseFotios S Fousekis, André Jefremow, Konstantinos H Katsanos, et al.
The Journal of Experimental Medicine|November 25, 2010
VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancerMaximilian J Waldner, Stefan Wirtz, André Jefremow, et al.
Gastroenterology|September 21, 2023
p21 Prevents the Exhaustion of CD4<sup>+</sup> T Cells Within the Antitumor Immune Response Against Colorectal CancerOana-Maria Thoma, Elisabeth Naschberger, Markéta Kubánková, et al.
Journal of Crohn'S & Colitis|August 30, 2024
Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel DiseaseDominik Roth, Miriam M Düll, Ludwig J Horst, et al.
Pageof 2